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Organ transplant recipients are known for car-
rying a high risk of various benign and malignant
tumor development, particularly of the skin.
Therapeutic immunosuppression in association
with a variety of (co-)carcinogenic factors are held
responsible for the high tumor incidence.
Acantholytic dyskeratotic acanthoma is a rare
benign condition characterized by circumscribedFig 1. Acantholytic dyskeratotic acanthomas. Clin
A, Overview shows the distribution of the lesions.
back.
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and dyskeratosis. Clinically, most cases were first
diagnosed as basal cell carcinoma, which prompted
their excision and histopathologic examination.
CASE REPORT
A 60-year-old man underwent heart transplanta-
tion because of severe dilatative cardiomyopathy in
2016. He receivedmycophenolatemofetil, tacrolimus,ical aspect of the lesions on the lower back.
B, Detailed clinical aspect of a lesion on the
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Fig 2. Histopathology of an acantholytic dyskeratotic
acanthoma. A, Scanning magnification of the tumor shows
a hyperkeratotic acanthoma with indentation on one side,
an obliquely upward-pointing column of dyskeratotic cells,
and marked acantholysis over most of the tumor width. B,
Higher magnification shows the suprabasal acantholysis,
dyskeratoses, and abnormally large round to oval cells with
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rejection.
In October 2017, a week after his wife had noticed
the lesions, he presented with multiple asymptom-
atic disseminated papules on his back and lateral
chest wall that demonstrated a slight central umbil-
ication or core (Fig 1). The patient had not received
dermatologic care before. No skin malignancies
were detected on full-body examination. The nails
were completely normal. Clinically, a perforating
collagenosis was suspected. A biopsy section was
taken for histopathologic examination.
The sections were stainedwith hematoxylin-eosin
and periodic acideSchiff. Serial and step sections
showed very characteristic changes. On one side of
the lesion, there was an angled indentation of the
epidermis with marked dyskeratosis and acanthol-
ysis of the keratinocytes in the bottom (Fig 2, A). In
particular, some very large acantholytic dyskeratotic
cells with hyperchromatic nuclei and eosinophilic
perinuclear shells representing rings of condensed
tonofilaments around the nucleus were observed
(Fig 2, B). Otherwise there was no conspicuous
cellular atypia. From here, a column of dyskeratotic
cells extended obliquely upward, giving the lesion a
slight resemblance to porokeratosis. In the first
biopsy, the acantholysis extended to the side, to
which the dyskeratotic column was leaning, but it
becamemore superficial and almost no dyskeratoses
were formed here. Based on these observations, an
acantholytic dyskeratotic acanthoma was diagnosed.
Because of this unique finding, 2 more excisions
were performed that showed the same histopatho-
logic changes, thus confirming that all lesions were
indeed acantholytic dyskeratotic acanthomas.a clear cytoplasmic periphery. (A and B, Hematoxylin-
eosin stain; original magnifications: A, 340; B, 3200.)DISCUSSION
Acantholytic dyskeratotic acanthoma is a rare
benign lesion of unknown etiology and pathogen-
esis.1 The striking features of acantholysis and
dyskeratosis are also seen in other dermatoses,2
particularly Darier dyskeratosis follicularis,
pemphigus benignus familiaris of Hailey-Hailey,
Grover transitory acantholytic dermatosis, warty
dyskeratoma,3 acantholytic dyskeratotic epidermal
nevus,4 and acantholytic squamous cell carcinoma.5
Rarely, acantholytic acanthomas without major dys-
keratosis or dyskeratotic acanthomas without acan-
tholysis are seen.6,7 However, dyskeratotic
acanthoma is not a variant of epidermolytic acan-
thoma,2,8 as dyskeratosis and epidermolytic hyper-
keratosis with its underlying granular degeneration
are fundamentally different processes. Most acan-
tholytic dyskeratotic acanthoma lesions are localizedon the trunk.9 Subungual localization was published
in 3 cases10 and seen by us in 4 cases (unpublished).
As the main differential diagnosis in our case, we
ruled out Grover transitory acantholytic dermatosis
because of clinical features of missing pruritus and
distribution (disseminated lesions just on the back)
and histologic features; an asymmetric angled inden-
tation, such a high amount of dyskeratotic hyper-
keratosis, and the column of dyskeratotic cells are
not seen in Grover transitory acantholytic derma-
tosis. We also ruled out multiple warty dyskeratomas
because this entity histologically shows a symmetric
endophytic tumor, which is not the case in our
patient. None of the other above-mentioned derma-
toses with acantholysis and dyskeratosis are clini-
cally or histologically consistent with our case.
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acanthoma remains unknown. One case was
described in a patient undergoing vemurafenib
therapy for metastasizing melanoma, and a mecha-
nism similar to that causing multiple keratoacantho-
mas in these patients was suggested.8 We are not
aware that any of the immunosuppressive drugs
taken by our patient has a similar action. However,
immunosuppression might allow cell clones prone
to undergo dyskeratosis and acantholysis to prolif-
erate, which otherwise might have been eliminated
by the immune system.
To the best of our knowledge, multiple acantho-
lytic dyskeratotic acanthomas have not yet been
described. It is tempting to speculate that the immu-
nosuppression necessary in organ transplant recipi-
ents may have prevented the elimination of those cell
clones that give rise to this peculiar benign lesion.
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